Ripisartan

DB20229ExperimentalSmall molecule

Ripisartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Ripisartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). Ripisartan has a... Ripisartan has a monoisotopic molecular weight of 426.19 Da.

Formula / weight: C₂₃H₂₂N₈O · 426.484 g/mol (avg)
Code names: UP-2696

Resolves to

Compound

UNII7LQ7OQP653CAS148504-51-2ChEMBLCHEMBL312104

Structure

InChIKeyOLJAPHMBAMBVKL-UHFFFAOYSA-NSMILESCCCC1=C(CC2=CC=C(C=C2)C2=C(C=CC=C2)C2=NN=NN2)C2=NC(=O)NN2C(C)=N1

Targets

P30556AGTR1

What you can answer from here — as of September 20, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ripisartan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account